Glen Harbor Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $293K | Buy |
10,230
+550
| +6% | +$15.8K | 0.01% | 891 |
|
|
2019
Q2 | $269K | Buy |
9,680
+418
| +5% | +$11.6K | 0.01% | 930 |
|
|
2019
Q1 | $308K | Hold |
9,262
| – | – | 0.01% | 854 |
|
|
2018
Q4 | $269K | Hold |
9,262
| – | – | 0.01% | 855 |
|
|
2018
Q3 | $426K | Buy |
9,262
+594
| +7% | +$27.3K | 0.01% | 786 |
|
|
2018
Q2 | $324K | Hold |
8,668
| – | – | 0.01% | 809 |
|
|
2018
Q1 | $256K | Buy |
8,668
+1,342
| +18% | +$39.6K | 0.01% | 883 |
|
|
2017
Q4 | $252K | Buy |
7,326
+1,188
| +19% | +$40.9K | 0.01% | 892 |
|
|
2017
Q3 | $222K | Buy |
6,138
+990
| +19% | +$35.8K | 0.01% | 872 |
|
|
2017
Q2 | $133K | Buy |
5,148
+2,332
| +83% | +$60.2K | ﹤0.01% | 994 |
|
|
2017
Q1 | $54K | Buy |
+2,816
| New | +$54K | ﹤0.01% | 1111 |
|